Clinical Trial Update: Self-Propelled Percutaneous Endoscopic GastroJejunostomy (PEG-J) [Phase 2]

View source ↗

Summary

Phase 2 trial update on a self-propelled percutaneous endoscopic gastrojejunostomy (PEG-J) procedure for gastroesophageal reflux disease; the study was terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: Johns Hopkins University | Conditions: GERD | Phase 2 | Status: TERMINATED | Results posted: 2016-10-12